824 results on '"Koch, Michael O."'
Search Results
2. PD01-05 ANALYZING THE PERCENTAGE OF POSITIVE 68GA-PSMA-PET/CT SCANS BASED ON PSA RANGES ACROSS DISTINCT INDICATIONS FOR THE SCAN
3. PD17-10 PREDICTING POSITIVE 68GA-PSMA PET/CT SCANS IN BIOCHEMICAL RECURRENCE FOLLOWING PROSTATECTOMY
4. What the Urologist Wants to Know from Prostate MRI
5. Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic Database
6. Photoacoustic tomography of intact human prostates and vascular texture analysis identify prostate cancer biopsy targets
7. Metabolic and Nutritional Consequences of Urinary Diversion Using Intestinal Segments to Reconstruct the Urinary Tract
8. A Prospective Program to Reduce the Clinical Incidence of Clostridium Difficile Colitis Infection after Cystectomy
9. Barriers to Single-Dose Intravesical Chemotherapy in Non-muscle Invasive Bladder Cancer: Whatʼs the Problem?
10. Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy
11. Supplementary Figure Legend from A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
12. Robotic Tubularized Peritoneal Vaginoplasty
13. Assessing extra-prostatic extension for surgical guidance in prostate cancer: Comparing two PSMA-PET tracers with the standard-of-care
14. Does Squamous Differentiation Portend Worse Outcomes in Urothelial Bladder Cancer?
15. Is the PSA Era Over?
16. Short-term morbidity and mortality of Indiana pouch, ileal conduit, and neobladder urinary diversion following radical cystectomy
17. Molecular characteristics of urothelial neoplasms in children and young adults: a subset of tumors from young patients harbors chromosomal abnormalities but not FGFR3 or TP53 gene mutations
18. Critical analysis of the 2010 TNM classification in patients with lymph node–positive bladder cancer: Influence of lymph node disease burden
19. Laparoscopic and Robotic-Assisted Laparoscopic Radical Prostatectomy
20. National trends in the utilization of robotic-assisted radical cystectomy: An analysis using the Nationwide Inpatient Sample
21. Plasmacytoid variant urothelial bladder cancer: Is it time to update the treatment paradigm?
22. EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder
23. Open vs. robotic-assisted radical prostatectomy: A single surgeon and pathologist comparison of pathologic and oncologic outcomes
24. Novel markers of squamous differentiation in the urinary bladder
25. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers
26. Perioperative Management of Radical Prostatectomy : The Impact of Critical Care Pathways
27. A Critical Assessment of Post-Prostatectomy Prostate Specific Antigen Doubling Time Acceleration—Is it Stable?
28. High-intensity focused ultrasound for the treatment of prostate cancer: assessing location of failure after focal therapy in prostate cancer and review of histological characteristics and clinicopathologic correlates after treatment—a 5-year experience
29. List of Contributors
30. High-Intensity Focused Ultrasound
31. Imaging Techniques for the Patient With Renal Cell Carcinoma
32. Tumor Focality Does Not Predict Biochemical Recurrence After Radical Prostatectomy in Men With Clinically Localized Prostate Cancer
33. A Parallel Randomized Clinical Trial Examining the Return of Urinary Continence after Robot-Assisted Radical Prostatectomy with or without a Small Intestinal Submucosa Bladder Neck Sling
34. Robotic versus Open Prostatectomy: End of the Controversy
35. EDITORIAL COMMENT
36. ADJUSTED CLINICAL OUTCOMES IN PATIENTS WITH SARCOMATOID VARIANT UROTHELIAL CARCINOMA UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE DISEASE: PD33-03
37. EMPIRIC TREATMENT OF IDENTIFIED CLOSTRIDIUM DIFFICILE CARRIERS AT TIME OF CYSTECTOMY: PRELIMINARY OUTCOMES: MP56-02
38. IMPACT OF OBESITY ON WOUND COMPLICATIONS FOLLOWING RADICAL PROSTATECTOMY IS MITIGATED BY ROBOTIC TECHNIQUE: MP23-04
39. Ranking Important Factors for Using Postoperative Chemotherapy in Non-Muscle Invasive Bladder Cancer: Conjoint Analysis Results From the Michigan Urological Surgery Improvement Collaborative (MUSIC)
40. Focal High-Intensity Focused Ultrasound Ablation of the Prostate
41. The changing reality of urothelial bladder cancer: should non-squamous variant histology be managed as a distinct clinical entity?
42. MP64-17 LACK OF IMPROVEMENT IN RADICAL CYSTECTOMY OUTCOMES OVER 20 YEARS?
43. MP58-11 DOES SQUAMOUS DIFFERENTIATION PORTEND WORSE OUTCOMES IN UROTHELIAL BLADDER CANCER?
44. PD15-03 RANDOMIZED CLINICAL TRIAL EXAMINING THE RETURN OF URINARY CONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH OR WITHOUT A BLADDER NECK SLING
45. Longitudinal Health Related Quality of Life After Open Radical Cystectomy: Comparison of Ileal Conduit, Indiana Pouch, and Orthotopic Neobladder
46. Multivariate statistical differentiation of renal cell carcinomas based on lipidomic analysis by ambient ionization imaging mass spectrometry
47. Incidence and Risk Factors of Parastomal Hernia in Patients Undergoing Radical Cystectomy and Ileal Conduit Diversion
48. CAN LYMPHOVASCULAR INVASION BE USED AS A SURROGATE FOR LYMPH NODE INVOLVEMENT IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA?: MP77-18
49. PROPOSED NODAL STAGING CLASSIFICATION IN UROTHELIAL CARCINOMA OF THE BLADDER BASED ON BURDEN OF LYMPH LODE INVOLVEMENT: MP65-17
50. EFFICACY OF NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER: MP55-19
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.